Horus® ليزر الألياف الضوئية DCR

Horus® ليزر الألياف الضوئية DCR

A تيتانيوم أو سبيكة نظام الصفيحة القصية الذي يوفر جامدة التثبيت بعد بضع القص في منتصف الخط الوسطي، وتعزيز الثبات القصي وتقليل مخاطر الإصابة بالعدوى أو النزف بعد جراحة القلب.

المعلومات

Horus® Fiber Optic Laser DCR by Invamed is specifically designed for minimally invasive tear duct surgery (dacryocystorhinostomy) using endoscopic laser technology. This system integrates high-performance fiber optics with precise laser control, enabling surgeons to create a new tear drainage pathway while minimizing trauma to surrounding nasal and lacrimal structures. The result is enhanced visualization, swift recovery, and long-term lacrimal system patency for patients suffering from nasolacrimal duct obstruction.

Targeted Laser Fiber Optic Delivery
  • إن fiber optic cable is engineered to channel laser energy directly to the lacrimal sac and nasal cavity junction, ensuring a clean and focused ablation path.
  • Minimizes collateral tissue damage around delicate nasal mucosa and lacrimal sac structures.
  • Utilizes a medical-grade laser (diode or holmium, based on product code) for consistent power delivery.
  • Offers variable laser energy settings, allowing surgeons to adjust ablation intensity to address different tissue thicknesses or scarring.
  • Horus® fiber is fabricated from medical-grade fused silica and covered with a durable polymer sheath resistant to repeated sterilization.
  • Maintains optimal light and laser transmission throughout the procedure, preserving brightness and laser focus.
  • Universal fiber connectors adapt to standard endoscopic lasers or integrated ENT/ophthalmic workstations, streamlining OR setups.
  • Compatible with endoscopic camera systems, facilitating simultaneous visualization of the operative field and precise laser fiber placement.
  • Reduces external scarring compared to external DCR techniques, enabling faster healing and improved cosmetic outcomes.
  • Well-suited for patients with nasolacrimal duct obstructions requiring direct endonasal access and laser-based tissue ablation.
  • Primary or revision endoscopic dacryocystorhinostomy in patients with chronic tear duct obstruction, failed nasolacrimal stent treatments, or recurrent dacryocystitis.
  • Especially beneficial for scarred anatomies or when alternative approaches have proven challenging.

منتجات ذات صلة